Financial Partners Capital Management LLC Biogen Inc. Transaction History

Financial Partners Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Feb 27, 2023	SELL	$282.99 - $369.05 $182,811 - $238,406	-646 Closed	0 $0
Q2 2021 Feb 27, 2023	BUY	$259.0 - $414.71 $167,314 - $267,902	646 New	646 $223,000
Q3 2020 Feb 28, 2023	SELL	$264.77 - $305.71 $174,483 - $201,462	-659 Closed	0 $0
Q1 2020 Feb 28, 2023	BUY	$268.85 - $341.04 $177,172 - $224,745	659 New	659 $208,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Financial Partners Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Partners Capital Management LLC with notifications on news.